Company Profile
Catheter Precision Stock Price, News & Catalysts
- Ticker:
- VTAK
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
1.51 USD (+893.42%)
Close
Last updated: October 2, 2026
2.58M USD
Market cap
Why the stock is moving
Current closing-price context is not available for VTAK.
Company overview
Cardiac Electrophysiology and Aviation Company
Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE. The company therefore operates through two distinct segments.
VIVO Cardiac Mapping System
VIVO is a non-invasive three-dimensional mapping system used to localize the origin of ventricular arrhythmias before an electrophysiology procedure. The technology combines a standard electrocardiogram with cardiac imaging data.
LockeT Suture Retention Device
LockeT temporarily secures sutures used to close vascular access sites after catheter-based procedures. Its design distributes tension and helps clinicians find and remove the suture efficiently.
Electrophysiology Commercial Model
VIVO is sold to hospitals and electrophysiology centers, while LockeT is a single-use product that can generate recurring procedure-based demand. U.S. direct activity and international distributors support commercialization.
Private Aviation Segment
Through acquired subsidiaries, the company provides private-aircraft charter services. This segment diversifies revenue but is operationally separate from the cardiac-device business.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Catheter Precision (VTAK)?
Catheter Precision (VTAK) most recently closed at 1.51 USD, a +893.42% move versus the previous session.
What is the market cap of Catheter Precision (VTAK)?
Catheter Precision currently has a market capitalization of 2.58M USD on BioPharmSignal.
What does Catheter Precision do?
Cardiac Electrophysiology and Aviation Company Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE. The company therefore operates through two distinct segments. VIVO Cardiac Mapping System VIVO is a non-invasive three-dimensional mapping system used to localize the...
On which exchange is VTAK stock listed?
Catheter Precision (VTAK) is associated with NYSE, United States, MedTech.
What is Cardiac?
Cardiac Electrophysiology and Aviation Company Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE.
Which conditions is Catheter Precision targeting with Cardiac?
Cardiac Electrophysiology and Aviation Company Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE. The company therefore operates through two distinct segments. VIVO Cardiac Mapping System VIVO is a non-invasive three-dimensional mapping system used to localize the...
What is Electrophysiology?
Cardiac Electrophysiology and Aviation Company Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE.
What is Aviation?
Cardiac Electrophysiology and Aviation Company Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE.